Viral Respiratory Infection Treatment Methods, Gradalis, Inc., EP4158025A1
Summary
The European Patent Office published application EP4158025A1 for Gradalis, Inc. on April 15, 2026. The patent covers methods for treating viral respiratory infections using nucleic acid sequences classified under C12N 15/113, with pharmaceutical compositions containing A61K 38/19 and A61K 31/713. The application designates 31 European states including AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, and TR. Inventors include David Shanahan, John Nemunaitis, and Ernest Bognar.
About this source
GovPing monitors EPO Patent Bulletin - Biotech (C12N) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 61 changes logged to date.
What changed
The EPO published patent application EP4158025A1 for Gradalis, Inc., covering methods of treating viral respiratory infections. The application claims compositions including C12N 15/113 nucleic acid sequences, A61K 38/19 protein compositions, and A61K 31/713 antisense or short interfering RNA formulations targeting A61P 31/14 viral pathogens and A61P 11/00 respiratory conditions. The patent provides Gradalis exclusive rights across 31 designated European contracting states for the claimed therapeutic methods.
Pharmaceutical and biotechnology companies developing RNA-based or nucleic acid-based antiviral respiratory therapies should review the claims of EP4158025A1 to assess potential freedom-to-operate considerations in European markets. Generic drug manufacturers and biosimilar developers may need to design around these claims when developing competing respiratory infection treatments for the designated states.
Archived snapshot
Apr 25, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
METHODS FOR THE TREATMENT OF VIRAL RESPIRATORY INFECTIONS
Publication EP4158025A1 Kind: A1 Apr 15, 2026
Applicants
Gradalis, Inc.
Inventors
SHANAHAN, David, NEMUNAITIS, John, BOGNAR, Ernest
IPC Classifications
C12N 15/113 20100101AFI20211203BHEP A61K 38/19 20060101ALI20211203BHEP A61K 31/713 20060101ALI20211203BHEP A61P 31/14 20060101ALI20211203BHEP A61P 11/00 20060101ALI20211203BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Parties
Related changes
Get daily alerts for EPO Patent Bulletin - Biotech (C12N)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Biotech (C12N) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.